Cargando…
Electro-mediated drug administration of mitomycin C in preventing non-muscle-invasive bladder cancer recurrence and progression after transurethral resection of the bladder tumour in intermediate- and high-risk patients
OBJECTIVE: To evaluate the effectiveness of electro-mediated drug administration of mitomycin C (EMDA/MMC) after transurethral resection of the bladder tumour (TURBT) in preventing non-muscle-invasive bladder cancer (NMIBC) recurrence and progression and to explore clinical and demographic factors a...
Autores principales: | Carando, Roberto, Soldini, Emiliano, Cotrufo, Simone, Zazzara, Michele, Ludovico, Giuseppe M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954506/ https://www.ncbi.nlm.nih.gov/pubmed/33763251 http://dx.doi.org/10.1080/2090598X.2020.1816150 |
Ejemplares similares
-
Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer
por: Nowak, Łukasz, et al.
Publicado: (2021) -
Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure
por: Chiancone, Francesco, et al.
Publicado: (2021) -
The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status
por: Nowak, Łukasz, et al.
Publicado: (2020) -
Transurethral resection of bladder tumour (TURBT)
por: Kim, Lawrence H. C., et al.
Publicado: (2020) -
Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)